BiotechTube
Home/Alkermes/Blair Jackson
BJ

Blair Jackson

Executive Vice President, Chief Operating Officer

Alkermes

Therapeutic Areas

PsychiatryNeurologySleep DisordersAddiction

Alkermes Pipeline

DrugIndicationPhase
Alixorexton (ALKS 2680)Narcolepsy Type 1Phase 3
Sodium Oxybate Extended-Release Oral SuspensionIdiopathic HypersomniaPhase 3
Olanzapine and SamidorphanSchizophrenia and Bipolar I Disorder (Pediatric)Phase 3

Leadership Team at Alkermes

RP
Richard Pops
Chairman and Chief Executive Officer
SC
Sandy Coombs
Senior Vice President, Corporate Affairs and Investor Relations
GD
Grace Doyle
Senior Vice President, Quality
CE
Colleen Ellwanger
Senior Vice President, Program and Project Management Office
DG
David Gaffin
Executive Vice President, Chief Legal Officer, Chief Compliance Officer and Secretary
AG
Anne Giovanoni
Senior Vice President, Corporate Counsel and Secretary
JH
Jeffrey Harris
Senior Vice President & General Manager, Psychiatry/Addiction Business Unit
TH
Thomas Harvey
Senior Vice President, IT and Chief Information Officer
DJ
Dr. Julie Lekstrom Himes
Senior Vice President, Clinical Development
DC
Dr. Craig Hopkinson
Executive Vice President, Research & Development and Chief Medical Officer
View full Alkermes profile